There’s Another Big Weight Loss Drug Coming — and It’s Not Made by Lilly

CagriSema FDA approval submission filed Dec 2025 by Novo Nordisk. 22.7% weight loss in REDEFINE 1, beat semaglutide alone. Here’s how it stacks up to tirzepatide and retatrutide.